• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型的核因子κB受体激活剂(RANK)细胞质基序通过使巨噬细胞定向分化为破骨细胞谱系,在破骨细胞生成过程中发挥着至关重要的作用。

A novel receptor activator of NF-kappaB (RANK) cytoplasmic motif plays an essential role in osteoclastogenesis by committing macrophages to the osteoclast lineage.

作者信息

Xu Duorong, Wang Shunqing, Liu Wei, Liu Jianzhong, Feng Xu

机构信息

Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

出版信息

J Biol Chem. 2006 Feb 24;281(8):4678-90. doi: 10.1074/jbc.M510383200. Epub 2005 Dec 22.

DOI:10.1074/jbc.M510383200
PMID:16373338
Abstract

Receptor activator of NF-kappaB (RANK) ligand (RANKL) and its receptor RANK play an essential role in osteoclastogenesis and osteoclast function by activating several signaling pathways. However, several lines of evidence suggest that RANK also transmits an unidentified signaling pathway(s) essential for osteoclastogenesis. To identify the novel pathway(s), we carried out a detailed structure/function study of the RANK cytoplasmic domain. A series of studies using numerous deletion/point mutants elucidated a specific 4-amino acid motif (535IVVY538) essential for osteoclastogenesis. This novel motif plays a crucial role in committing macrophages to the osteoclast lineage but is not implicated in osteoclast function or survival. Moreover, this motif does not activate the known RANK signaling pathways, indicating that it initiates a novel pathway(s). The identification of the novel motif not only provides critical insight into RANK signaling in osteoclastogenesis, but more importantly, the RANK motif and its downstream signaling pathways may represent specific therapeutic targets for various bone diseases, including postmenopausal osteoporosis.

摘要

核因子κB受体激活剂(RANK)配体(RANKL)及其受体RANK通过激活多种信号通路在破骨细胞生成和破骨细胞功能中发挥重要作用。然而,多项证据表明,RANK还传递一条对破骨细胞生成至关重要的未知信号通路。为了鉴定这条新的信号通路,我们对RANK胞质结构域进行了详细的结构/功能研究。一系列使用大量缺失/点突变体的研究阐明了一个对破骨细胞生成至关重要的特定4氨基酸基序(535IVVY538)。这个新基序在使巨噬细胞定向分化为破骨细胞谱系中起关键作用,但与破骨细胞功能或存活无关。此外,该基序不激活已知的RANK信号通路,表明它启动了一条新的信号通路。新基序的鉴定不仅为破骨细胞生成过程中的RANK信号传导提供了关键见解,更重要的是,RANK基序及其下游信号通路可能代表包括绝经后骨质疏松症在内的各种骨疾病的特定治疗靶点。

相似文献

1
A novel receptor activator of NF-kappaB (RANK) cytoplasmic motif plays an essential role in osteoclastogenesis by committing macrophages to the osteoclast lineage.一种新型的核因子κB受体激活剂(RANK)细胞质基序通过使巨噬细胞定向分化为破骨细胞谱系,在破骨细胞生成过程中发挥着至关重要的作用。
J Biol Chem. 2006 Feb 24;281(8):4678-90. doi: 10.1074/jbc.M510383200. Epub 2005 Dec 22.
2
Functional identification of three receptor activator of NF-kappa B cytoplasmic motifs mediating osteoclast differentiation and function.介导破骨细胞分化和功能的三种核因子κB受体激活剂胞质基序的功能鉴定
J Biol Chem. 2004 Dec 24;279(52):54759-69. doi: 10.1074/jbc.M404687200. Epub 2004 Oct 12.
3
Receptor activator of NF-kappaB (RANK) cytoplasmic motif, 369PFQEP373, plays a predominant role in osteoclast survival in part by activating Akt/PKB and its downstream effector AFX/FOXO4.核因子κB受体激活剂(RANK)的胞质基序,369PFQEP373,部分通过激活Akt/PKB及其下游效应物AFX/FOXO4在破骨细胞存活中起主要作用。
J Biol Chem. 2005 Dec 30;280(52):43064-72. doi: 10.1074/jbc.M509006200. Epub 2005 Oct 31.
4
Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.核因子-κB 受体激活剂信号对白细胞介素 1 介导的破骨细胞生成的需求的分子基础。
J Biol Chem. 2012 May 4;287(19):15728-38. doi: 10.1074/jbc.M111.296228. Epub 2012 Mar 13.
5
Receptor activator of NF-{kappa}B (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-{alpha} (TNF)-mediated osteoclastogenesis.核因子-κB(NF-κB)受体激活剂(RANK)胞质 IVVY535-538 基序在肿瘤坏死因子-α(TNF)介导的破骨细胞生成中起关键作用。
J Biol Chem. 2010 Nov 26;285(48):37427-35. doi: 10.1074/jbc.M110.149484. Epub 2010 Sep 24.
6
The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis.核因子κB受体激活剂(RANK)胞质结构域中的IVVY基序与肿瘤坏死因子受体相关因子(TRAF)位点协同诱导破骨细胞生成。
J Biol Chem. 2015 Sep 25;290(39):23738-50. doi: 10.1074/jbc.M115.667535. Epub 2015 Aug 14.
7
Self-assembled RANK induces osteoclastogenesis ligand-independently.自组装的RANK可独立于配体诱导破骨细胞生成。
J Bone Miner Res. 2005 Nov;20(11):2053-60. doi: 10.1359/JBMR.050706. Epub 2005 Jul 11.
8
Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.肿瘤坏死因子-α(TNF)通过肿瘤坏死因子1型受体与核因子κB受体活化因子(RANK)信号通路的偶联刺激RANK配体(RANKL)诱导的破骨细胞生成。
J Biol Chem. 2001 Jan 5;276(1):563-8. doi: 10.1074/jbc.M008198200.
9
TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.TRAF2对于肿瘤坏死因子-α诱导的破骨细胞生成至关重要。
J Bone Miner Res. 2005 May;20(5):840-7. doi: 10.1359/JBMR.041225. Epub 2004 Dec 20.
10
Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.激活素A刺激破骨细胞前体中IkappaB-α/NFkappaB和RANK的表达以促进破骨细胞分化,但不刺激AKT存活通路。
J Cell Biochem. 2003 Sep 1;90(1):59-67. doi: 10.1002/jcb.10613.

引用本文的文献

1
RANK IVVY motif plays crucial roles in osteoclastogenesis.RANK IVVY基序在破骨细胞生成中起关键作用。
Bone. 2025 Mar;192:117367. doi: 10.1016/j.bone.2024.117367. Epub 2024 Dec 10.
2
Specific RANK Cytoplasmic Motifs Drive Osteoclastogenesis.特定的 RANK 细胞质基序驱动破骨细胞生成。
J Bone Miner Res. 2019 Oct;34(10):1938-1951. doi: 10.1002/jbmr.3810. Epub 2019 Aug 2.
3
STAC2 negatively regulates osteoclast formation by targeting the RANK signaling complex.STAC2 通过靶向 RANK 信号复合物负调控破骨细胞的形成。
Cell Death Differ. 2018 Aug;25(8):1364-1374. doi: 10.1038/s41418-017-0048-5. Epub 2018 Jan 18.
4
C/EBPα transcription factor is regulated by the RANK cytoplasmic IVVY motif and stimulates osteoclastogenesis more strongly than c-Fos.C/EBPα 转录因子受 RANK 细胞质 IVVY 基序调节,比 c-Fos 更能强烈刺激破骨细胞生成。
J Biol Chem. 2018 Jan 26;293(4):1480-1492. doi: 10.1074/jbc.M116.736009. Epub 2017 Nov 9.
5
C/EBPα and PU.1 exhibit different responses to RANK signaling for osteoclastogenesis.C/EBPα 和 PU.1 对破骨细胞生成的 RANK 信号有不同的反应。
Bone. 2018 Feb;107:104-114. doi: 10.1016/j.bone.2017.05.009. Epub 2017 Oct 12.
6
Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis.肿瘤坏死因子受体相关因子6(TRAF6)与Vav3在核因子κB受体激活剂(RANK)信号复合物中的相互作用增强破骨细胞生成。
J Biol Chem. 2016 Sep 23;291(39):20643-60. doi: 10.1074/jbc.M116.728303. Epub 2016 Aug 9.
7
CCAAT/Enhancer-binding Protein α (C/EBPα) Is Important for Osteoclast Differentiation and Activity.CCAAT/增强子结合蛋白α(C/EBPα)对破骨细胞的分化和活性至关重要。
J Biol Chem. 2016 Jul 29;291(31):16390-403. doi: 10.1074/jbc.M115.674598. Epub 2016 Apr 20.
8
Smad7 interrupts TGF-β signaling in intestinal macrophages and promotes inflammatory activation of these cells during necrotizing enterocolitis.Smad7在肠道巨噬细胞中阻断转化生长因子-β信号通路,并在坏死性小肠结肠炎期间促进这些细胞的炎症激活。
Pediatr Res. 2016 Jun;79(6):951-61. doi: 10.1038/pr.2016.18. Epub 2016 Feb 9.
9
The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis.核因子κB受体激活剂(RANK)胞质结构域中的IVVY基序与肿瘤坏死因子受体相关因子(TRAF)位点协同诱导破骨细胞生成。
J Biol Chem. 2015 Sep 25;290(39):23738-50. doi: 10.1074/jbc.M115.667535. Epub 2015 Aug 14.
10
Osteoclasts: New Insights.破骨细胞:新的认识。
Bone Res. 2013 Mar 29;1(1):11-26. doi: 10.4248/BR201301003. eCollection 2013 Mar.